North America Molecular Diagnostics Market to be Worth $18.13 Billion by 2030 North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User - Forecast to 2030 ________________________________________ Meticulous Research®, a leading global market research company, published a research report titled, ‘North America Molecular Diagnostics Market by Product (Reagents & Kits, Systems, Software), Test Type (Lab, PoC), Technology (PCR, ISH, INAAT, Sequencing, Microarray), Application (Infectious Diseases, Oncology, Neurological), End User—Forecast to 2030.’ According to this latest publication from Meticulous Research®, the North America molecular diagnostics market is expected to reach $18.13 billion by 2030 at a CAGR of 5.3% from 2023 to 2030. The growth of the North America molecular diagnostics market is driven by several factors, including the rising geriatric population, the increasing prevalence of communicable & non-communicable diseases, technological advancements in molecular diagnostics, and rising healthcare expenditures. However, unfavorable regulatory frameworks and the high costs of molecular diagnostic tests restrain the growth of this market. Furthermore, increasing focus on companion diagnostics and the rising popularity of direct-to-consumer (DTC) genetic testing are expected to create growth opportunities for the players in this market. However, the shortage of skilled professionals is a major challenge for market growth. Additionally, the rising integration of artificial intelligence & machine learning is a prominent trend in the molecular diagnostics market. Key Players The key players operating in the North America molecular diagnostics market are Hologic, Inc. (U.S.), Danaher Corporation (U.S.), BioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Siemens Healthineers AG (Germany), DiaSorin S.p.A. (Italy), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Illumina, Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), QIAGEN N.V. (Netherlands), and Seegene, Inc. (South Korea). North America Molecular Diagnostics Market: Future Outlook Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642 Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5642 Geographic Review This research report comprehensively analyzes the major countries in North America (U.S. and Canada). In 2023, the U.S. is expected to account for the largest share of the North America molecular diagnostics market. In the U.S., the number of people aged 65 and above is increasing rapidly. The number of senior citizens is projected to increase from 56.0 million in 2020 to 94.7 million in 2060. Additionally, the number of people aged 85 and above is projected to nearly triple from 6.7 million in 2020 to 19.0 million by 2060. The aging population is vulnerable to various diseases and is more likely to go to the hospital for infectious diseases. In addition, the aging population is prone to Alzheimer’s disease and other types of dementia and is more likely to be hospitalized. Hence, the growing geriatric population will require frequent diagnostic testing, increasing the demand for molecular diagnostic products. Quick Buy: https://www.meticulousresearch.com/Checkout/41114062 Key questions answered in the report- • Which are the high-growth market segments in terms of product & service, test type, technology, application, end user, and geography? • What was the historical market for molecular diagnostics across North America? • What are the market forecasts and estimates for the period 2023–2030? • What are the major drivers, restraints, opportunities, and challenges in the North America molecular diagnostics market? • Who are the major players in the North America molecular diagnostics market? • What is the competitive landscape, and who are the market leaders in the North America molecular diagnostics market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5642 Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031 ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’ Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 Key Players The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.). Asia-Pacific IVD Market: Future Outlook The Asia-Pacific IVD market is segmented by Offering (Kits & Reagents, Instruments, and Software & Services), Technology (Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Molecular Diagnostics, Point of Care (POC) Diagnostics, Whole Blood Glucose Monitoring, Microbiology, Hematology, Coagulation/Hemostasis, Urinalysis, and Other Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, OTC/Self-testing, and Point of Care Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Home Healthcare, and Other End Users), and Countries. The study also evaluates industry competitors and analyzes their market share at the country level. 𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750 by Offering • Kits & Reagents • Instruments • Software & Services by Technology • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Hybridization o Isothermal Nucleic Acid Amplification Technology o DNA Sequencing & Next-generation Sequencing o Microarrays o Mass Spectrometry o Other Molecular Diagnostic Technologies • Point of Care (PoC) Diagnostics o Lateral Flow Assays/Rapid Tests o POC Molecular Diagnostics o Other PoC Products • Immunoassay/Immunochemistry o Enzyme-linked Immunosorbent Assays (ELISA) o Radioimmunoassays o Western Blotting o Enzyme-Linked Immunospot Assays o Immunohistochemistry (IHC) • Biochemistry/Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Whole Blood Glucose Monitoring • Microbiology • Hematology • Coagulation/Hemostasis • Urinalysis • Other IVD Technologies by Application • Infectious Diseases o COVID-19 Testing o Sexually Transmitted Diseases (STD) Testing o Healthcare-associated Infections (HAIs) o Hepatitis o HIV o Tropical Diseases o Respiratory Infections (Excluding Influenza) o Influenza o Other Infectious Diseases • Oncology • Diabetes • Cardiology • Nephrology • Autoimmune Disorders • Other Applications by Diagnostic Approach • Lab Testing • OTC/Self-testing • Point of Care Testing by End User • Diagnostic Laboratories • Hospitals & Clinics • Home Healthcare • Other End Users by Country/Region • China • Japan • India • Australia • South Korea • Thailand • Singapore • Indonesia • Rest of Asia-Pacific Browse Here: https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750 Geographic Review Key questions answered in the report: • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country? • What was the historical market for IVD testing in Asia-Pacific? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market? • Who are the major players in the Asia-Pacific IVD market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 ContactUs: MeticulousResearch® Email- [email protected] ContactSales-+1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Top 10 Companies Leading the IVD Quality Control Market: A Comprehensive Overview The IVD Quality Control Market is a significant and growing sector within the healthcare industry. It plays a crucial role in ensuring the accuracy and reliability of in vitro diagnostic tests, which are essential for patient care. The market is expected to continue its growth, driven by various factors such as the rising prevalence of chronic diseases, the increasing geriatric population, the need for quality control assessments, and the demand for point-of-care testing. Here are the top 10 companies operating in this market: https://meticulousblog.org/top-10-companies-in-ivd-quality-control-market/ Siemens Healthineers AG (Germany): Siemens Healthineers is a global provider of healthcare solutions and services, with a focus on in vitro diagnostic quality control products. Bio-Rad Laboratories, Inc. (U.S.): Bio-Rad Laboratories is engaged in developing, manufacturing, and marketing products for life science research and clinical diagnosis, including quality control products. Danaher Corporation (U.S.): Danaher is a diversified company that designs, manufactures, and markets a wide range of professional, medical, industrial, and commercial products and services, including IVD quality control products. LGC Group (U.K.): LGC is a leading provider of products in various market segments, including clinical diagnostics. It offers IVD quality control products through its Clinical Diagnostics segment. Thermo Fisher Scientific Inc. (U.S.): Thermo Fisher Scientific is a global company that offers healthcare technologies, software, and services. It operates in the IVD quality control market through its Specialty Diagnostics segment. Randox Laboratories Ltd. (U.K.): Randox Laboratories is a prominent company in the field of in-vitro diagnostics, offering IVD quality control products and customized quality controls. QuidelOrtho Corporation (U.S.): QuidelOrtho Corporation develops and manufactures diagnostic solutions, with IVD quality control products falling under its Labs segment. Microbiologics, Inc. (U.S.): Microbiologics provides biological control materials, assay services, and consulting for microbiology, molecular diagnostics, and virology markets. Streck LLC (U.S.): Streck provides quality control and diagnostic products in various areas, including hematology, immunology, molecular diagnostics, and infectious diseases. SERO AS (Norway): SERO AS is a biotechnology company that manufactures quality control materials for laboratories, covering various clinical parameters. These companies offer a wide range of IVD quality control products and services to ensure the accuracy and reliability of diagnostic tests in clinical laboratories and point-of-care settings. As the healthcare industry continues to evolve, the role of these companies in maintaining high-quality diagnostics is vital for better patient outcomes and overall laboratory performance. Authoritative Research on the IVD Quality Control Market - Global Opportunity Analysis and Industry Forecast (2023–2030) Need more information? Meticulous Research®'s new report covers each of these companies in much more detail, providing analysis on the following: Recent financial performance Key products Significant company strategies Partnerships and acquisitions The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends. https://www.meticulousresearch.com/download-sample-report/cp_id=3447

A Complete Guide of " 𝑰𝒏 𝑽𝒊𝒕𝒓𝒐 𝑫𝒊𝒂𝒈𝒏𝒐𝒔𝒕𝒊𝒄𝒔" [ PDF Guide ] ▶ 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞 𝐅𝐨𝐫 𝐏𝐃𝐅 : https://lnkd.in/dawQnYha #clinicaldiagnostics , specifically In-vitro Diagnostics sector is highly dynamic, where market conditions change rapidly. In recent years, the #IVD industry has been going through seismic changes, focused on #digitization and enabling error-free and accurate diagnoses. Apart from this, #automation ,miniaturization , and portability, continues to play a critical role in innovation in innovation in the IVD industry. As #healthcare therapeutics evolve, IVD is becoming an essential part of next-generation therapies, such as #precisionmedicine and targeted therapies that treat patients or patient groups based on their molecular makeup. 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 1. Rising Prevalence of Communicable and Non-communicable Diseases 2. Growing Awareness Regarding Early #Disease Diagnosis 3. Adoption of Point-of-care Testing 4. Expanding #medicaltourism in the Region The Personalized Health Index is a first-of-its-kind, data-driven policy tool that measures each country's progress toward the personalized future of healthcare. #Uruguay held the first position in the Personalized Health Index for #latinamerica . Also, according to the Latin American Personalized Medicine Index, #Mexico is one of the top five Latin American countries with the best conditions to integrate and promote personalized medicine. Latin America performs best in personalized technologies such as devices, applications, and reimbursement structures that help drive personalized healthcare in the region. The countries in Latin America are progressing toward the adoption of personalized healthcare and medicine, providing opportunities for the IVD market in the region. The key players operating in the IVD market in Latin America are F. Hoffmann-La Roche Ltd. Siemens Healthineers Danaher Corporation Becton, Dickinson and Company bioMérieux QIAGEN Thermo Fisher Scientific Wama Diagnóstica ▶ 𝐎𝐮𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐁𝐥𝐨𝐠 : https://lnkd.in/d9fHnF_f #pointofcaretesting #moleculardiagnostics #immunoassay #poc #miniaturization #infectiousdiseases #diabetes #oncology #hematology #microbiology #invitrodiagnostics #invitro #medical #hospital #health #

Women's Healthcare: Empowering Women to Put Their Health First As females, we tend to overlook our health. All of our needs take a backseat and are hardly taken care of. This could lead to potential problems and issues. This article aims to shed light on the importance of Women's healthcare in White Plains, New York. It will highlight key areas of focus and emphasize the significance of self-care.  https://wphospitalny.wordpress.com/2023/07/05/womens-healthcare-empowering-women-to-put-their-health-first/

Wingcopter, Siemens Healthineers partner to deliver lab samples in Africa #news #Wingcopter #SiemensHealthineers #Africa #TomPlümmer #OleMaloy